Prognostic factors in unresectable hepatocellular cancer: Radiation therapy oncology group study 83-01 (Q41169623)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1847127%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

title

Prognostic factors in unresectable hepatocellular cancer: Radiation Therapy Oncology Group Study 83-01 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1847127%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Prognostic factors in unresectable hepatocellular cancer: Radiation therapy oncology group study 83-01 (English)

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

8 December 2022

main subject

hepatocellular carcinoma

1 reference

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

8 December 2022

author name string

G. B. Stillwagon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1847127

8 December 2022

S. E. Order

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1847127

8 December 2022

C. Guse

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1847127

8 December 2022

S. A. Leibel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1847127

8 December 2022

S. O. Asbell

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1847127

8 December 2022

J. L. Klein

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1847127

8 December 2022

P. K. Leichner

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1847127

8 December 2022

language of work or name

English

0 references

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1847127%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 September 2019

https://api.elsevier.com/content/article/PII:036030169190139U?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

https://api.elsevier.com/content/article/PII:036030169190139U?httpAccept=text/plain

8 December 2022

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

International Journal of Radiation Oncology Biology Physics

8 December 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1847127%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1847127%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1847127%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

65-71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1847127%20AND%20SRC:MED&resulttype=core&format=json

Primary carcinoma of the liver: a study of 282 cases in Ugandan Africans

19 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

Prognostic factors in patients with hepatocellular carcinoma. Attempts for the selection of patients with prolonged survival

8 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

Hepatocellular carcinoma. Polygonal cell type with fibrous stroma—an atypical variant with a favorable prognosis

8 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

The management of primary liver carcinoma

8 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

Hepatocellular carcinoma diagnostic and prognostic features in north american patients

8 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinoma

8 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies

8 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

Primary malignant tumors of the liver

8 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

Chemotherapy studies in primary liver cancer. A prospective randomized clinical trial

8 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

Malignant hepatoma in the Bantu

8 December 2022

15

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Identification of two groups of patients with prospects for prolonged survival

8 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

Nonparametric Estimation from Incomplete Observations

8 December 2022

19

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

Tumor Vascularity as a Prognostic Factor for Hepatic Tumors

8 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

Histologic prognostic indicators in hepatocellular carcinoma

8 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

A clinicopathological review of 100 cases of primary malignant tumours of the liver

8 December 2022

24

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

Evaluation of survival data and two new rank order statistics arising in its consideration

8 December 2022

25

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

Diagnostic and prognostic value of serum copper and plasma fibrinogen in hepatic carcinoma

8 December 2022

26

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

Prognosis of hepatocellular carcinoma smaller than 5 cm in relation to treatment: study of 100 patients

8 December 2022

28

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

Prognosis of primary hepatocellular carcinoma

8 December 2022

29

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

8 December 2022

30

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

The history and progress of serologic immunotherapy and radiodiagnosis

8 December 2022

32

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study

8 December 2022

33

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

90Yttrium antiferritin--a new therapeutic radiolabeled antibody

8 December 2022

34

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

PRIMARY LIVER CARCINOMA. AUTOPSY STUDY OF 60 CASES

8 December 2022

35

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

A staging system for hepatocellular carcinoma: Prognostic factors in Ugandan patients

8 December 2022

36

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

Alpha-fetoprotein: diagnostic and prognostic use in patients with hepatomas.

8 December 2022

37

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

Adriamycin treatment for hepatocellular carcinoma. Experience with 109 patients.

8 December 2022

38

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

Primary carcinomas of the liver and biliary tract

8 December 2022

39

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

194 hepatocellular cancers treated by radiation and chemotherapy combinations: toxicity and response: a Radiation Therapy Oncology Group Study

8 December 2022

40

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

Multi-modality treatment of primary nonresectable intrahepatic cholangiocarcinoma with 131I anti-CEA--a Radiation Therapy Oncology Group Study.

8 December 2022

41

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

Factors affecting the prognosis of primary liver carcinoma

8 December 2022

42

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

Hepatocellular carcinoma: importance of histologic classification as a prognostic factor

8 December 2022

43

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90139-U

8 December 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1847127%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference